MOBILE   |  REGISTER   |   LOGIN   |   HELP
HOME  |  ABOUT US  |  BLOGGERS  |  BLOGS  |  MESSAGES  |  VIDEO  |  QUIZZES  |  LIBRARY  |  WEBINARS
A Gated Community for Oncology Nurses and
Cancer Care Teams | More Info
Breast   |   Prostate   |   Lung   |   Hematology   |   Skin   |   Gastrointestinal   |   Genitourinary   |   Head / Neck   |   Brain   |   Gynecological   |   Sarcoma   |   Thyroid
Career  |  Exercise  |  Nutrition  |  Recipes  |  Survivorship  |  Symptom Management  |  Emergencies  |  Side Effects  |  Pediatrics  |  Complementary Therapies
Blog Roll
Deborah A. Boyle

Those Dread Words: 'It’s Back'

NO RATINGS
View Comments: Newest First | Oldest First | Threaded View
More Blogs from...
Deborah A. Boyle
The aggressiveness of cancer care near the end of life has emerged as both a quality and cost issue of critical importance.
The American Society of Clinical Oncology wrote a provisional clinical opinion on the integration of palliative care into standard cancer care.
The prominence of tobacco and its relationship to dying prematurely from cancer cannot be understated
Webinar Series
Tuesday, October 29, 2013 12:00 PM EDT
Archived

Presented by Ellen T. Matloff, MS, CGC , this webinar will highlight:

  • How to determine which patients require genetic counseling
  • How to help prepare your patients for the genetic counseling process
  • Testing options that are now available
  • How you can utilize this data in managing your patients and their family members

Participants will also be able to ask questions during a live question and answer period with speaker Ellen T. Matloff, MS, CGC .

Wednesday, August 28, 2013 12:00 PM EDT
Wednesday, June 26, 2013 12:00 PM EDT
Wednesday, April 10, 2013 12:00 PM EDT
Readerboards
Have a question or topic but don't want to write a blog? Post it on our readerboards and get feedback from the community!
karatx16 on Enhance your Business through Excellent Website Promotion
karatx16 on Enhance your Business through Excellent Website Promotion
karatx16 on Enhance your Business through Excellent Website Promotion
FDA Approves Onivyde for Advanced Pancreatic Cancer
Marijke Vroomen Durning, RN,
10/27/2015  3
On October 22, 2015, the US Food and Drug Administration (FDA) approved Onivyde (irinotecan liposome injection, Merrimack Pharmaceuticals, Inc.), in combination with fluorouracil ...
Like Us on Facebook
on Twitter
TheONC Twitter Feed
TheONC.org